Medifast (MED) Short Interest Ratio & Short Volume $13.27 +0.29 (+2.23%) Closing price 05/2/2025 03:59 PM EasternExtended Trading$13.29 +0.02 (+0.18%) As of 05/2/2025 06:44 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Medifast Short Interest DataMedifast (MED) has a short interest of 1.20 million shares, representing 11.45% of the float (the number of shares available for trading by the public). This marks a -13.04% decrease in short interest from the previous month. The short interest ratio (days to cover) is 5.3, indicating that it would take 5.3 days of the average trading volume of 307,303 shares to cover all short positions.Current Short Interest1,200,000 sharesPrevious Short Interest1,380,000 sharesChange Vs. Previous Month-13.04%Dollar Volume Sold Short$14.87 millionShort Interest Ratio5.3 Days to CoverLast Record DateApril 15, 2025Outstanding Shares10,991,000 sharesFloat Size10,480,000 sharesShort Percent of Float11.45%Today's Trading Volume266,292 sharesAverage Trading Volume307,303 sharesToday's Volume Vs. Average87% Short Selling Medifast? Sign up to receive the latest short interest report for Medifast and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartMED Short Interest Over TimeMED Days to Cover Over TimeMED Percentage of Float Shorted Over Time Medifast Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20251,200,000 shares $14.87 million -13.0%11.5%5.3 $12.39 3/31/20251,380,000 shares $18.64 million +7.0%13.2%6 $13.51 3/15/20251,290,000 shares $17.96 million -7.2%12.1%5.6 $13.93 2/28/20251,390,000 shares $19.99 million +3.7%13.1%5.9 $14.38 2/15/20251,340,000 shares $21.69 million -2.2%12.6%5.7 $16.19 1/31/20251,370,000 shares $21.48 million -2.1%12.9%6.2 $15.68 1/15/20251,400,000 shares $21.38 million +0.7%13.2%6.3 $15.27 12/31/20241,390,000 shares $24.49 million -1.4%13.1%6.5 $17.62 12/15/20241,410,000 shares $27.02 million -13.0%13.3%7.1 $19.16 11/30/20241,620,000 shares $31.87 million +1.3%15.3%8.3 $19.67 Get the Latest News and Ratings for MED and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Medifast and its competitors with MarketBeat's FREE daily newsletter. 11/15/20241,600,000 shares $29.02 million -3.0%15.1%8.5 $18.14 10/31/20241,650,000 shares $30.34 million -6.8%15.6%8.2 $18.39 10/15/20241,770,000 shares $31.52 million -3.8%16.7%7.4 $17.81 9/30/20241,840,000 shares $35.22 million -10.2%17.3%6.7 $19.14 9/15/20242,050,000 shares $38.75 million -1.0%19.3%6.2 $18.90 8/31/20242,070,000 shares $37.88 million -4.6%19.5%4.5 $18.30 8/15/20242,170,000 shares $40.11 million -21.4%20.5%4.2 $18.49 7/31/20242,760,000 shares $60.61 million -6.8%26.0%5.1 $21.96 7/15/20242,960,000 shares $55.20 million +0.7%27.9%5.1 $18.65 6/30/20242,940,000 shares $64.15 million -15.0%27.7%5.1 $21.82 6/15/20243,460,000 shares $68.20 million +0.6%32.5%6.1 $19.71 5/31/20243,440,000 shares $88.55 million +6.2%32.3%7 $25.74 5/15/20243,240,000 shares $82.10 million +3.9%30.4%7.2 $25.34 4/30/20243,120,000 shares $85.96 million +4.4%29.3%7 $27.55 4/15/20242,990,000 shares $93.74 million +12.4%28.2%8 $31.35 3/31/20242,660,000 shares $101.93 million +29.8%25.1%6.9 $38.32 3/15/20242,050,000 shares $74.95 million +5.7%19.3%5.6 $36.56 2/29/20241,940,000 shares $77.77 million +2.7%18.2%5.8 $40.09 2/15/20241,890,000 shares $96.99 million -1.6%17.8%6.2 $51.32 1/31/20241,920,000 shares $104.93 million +7.3%18.0%7.4 $54.65 1/15/20241,790,000 shares $109.49 million +3.5%16.7%7.2 $61.17 12/31/20231,730,000 shares $116.29 million -3.9%16.2%8.2 $67.22 12/15/20231,800,000 shares $122.94 million -1.1%16.8%9 $68.30 11/30/20231,820,000 shares $120.79 million +8.3%17.0%10.5 $66.37 11/15/20231,680,000 shares $114.91 million -2.9%15.7%9.9 $68.40 10/31/20231,730,000 shares $119.72 million -0.6%16.2%10.4 $69.21 10/15/20231,740,000 shares $126.29 million -1.1%16.3%10.3 $72.58 9/30/20231,760,000 shares $131.74 million +6.0%16.5%10.5 $74.85 9/15/20231,660,000 shares $134.73 million +1.8%15.5%9.5 $81.17 8/31/20231,630,000 shares $137.46 million +8.7%15.3%8.7 $84.33Trump Orders 'National Digital Asset Stockpile' (Ad)Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what could be the biggest wealth opportunity since Bitcoin's early days.Click Here to get our complete analysis on why this lending platform is our #1 "buy the dip" opportu 8/15/20231,500,000 shares $134.22 million +2.7%14.0%7.6 $89.48 7/31/20231,460,000 shares $148.38 million +0.7%13.8%7.2 $101.63 7/15/20231,450,000 shares $132.53 million -8.2%13.7%6.5 $91.40 6/30/20231,580,000 shares $145.72 million -0.6%14.9%7 $92.23 6/15/20231,590,000 shares $127.31 million +2.6%15.0%7.1 $80.07 5/31/20231,550,000 shares $121.97 million -4.9%14.6%7.2 $78.69 5/15/20231,630,000 shares $149.00 million -5.8%15.3%7.1 $91.41 4/30/20231,730,000 shares $158.55 million +9.5%16.3%7.3 $91.65 4/15/20231,580,000 shares $154.97 million +2.6%14.9%7.6 $98.08 3/31/20231,540,000 shares $159.65 million +0.7%14.5%7.5 $103.67 3/15/20231,530,000 shares $157.61 million -1.3%14.4%8.2 $103.01 2/28/20231,550,000 shares $173.80 million +31.4%14.6%9 $112.13 2/15/20231,180,000 shares $136.07 million +38.3%11.1%7.2 $115.31 1/31/2023853,300 shares $95.10 million +44.8%8.0%6 $111.45 1/15/2023589,500 shares $74.51 million +17.8%5.5%4.3 $126.39 12/30/2022500,400 shares $57.72 million -21.3%4.7%3.7 $115.35 12/15/2022635,500 shares $72.54 million +29.5%5.9%4.5 $114.14 11/30/2022490,800 shares $61.87 million -10.1%4.6%3.3 $126.05 11/15/2022545,800 shares $63.52 million -5.6%5.1%3.4 $116.38 10/31/2022578,300 shares $67.66 million -6.4%5.4%3.4 $116.99 10/15/2022617,800 shares $71.42 million +3.6%5.7%3.2 $115.60 9/30/2022596,200 shares $64.60 million -0.9%5.5%3.2 $108.36 9/15/2022601,700 shares $73.08 million -15.7%5.6%3.2 $121.45 8/31/2022713,300 shares $89.50 million -20.0%6.6%4 $125.48 8/15/2022891,500 shares $123.45 million +0.0%8.3%5.3 $138.48 7/31/2022891,100 shares $149.87 million -5.7%7.9%5.8 $168.19 7/15/2022944,800 shares $162.34 million +6.2%8.4%7.6 $171.83 6/30/2022890,100 shares $160.67 million -10.0%7.9%7.3 $180.51 6/15/2022989,100 shares $178.77 million +71.8%8.7%8.4 $180.74 5/31/2022575,700 shares $96.00 million -2.2%5.1%4.9 $166.75 5/15/2022588,400 shares $105.26 million +0.7%5.2%4.5 $178.89 4/30/2022584,100 shares $104.18 million +9.8%5.2%4.6 $178.36 4/15/2022532,200 shares $97.96 million -15.5%4.8%4.3 $184.06 3/31/2022629,700 shares $107.54 million +2.8%5.7%5 $170.78 3/15/2022612,500 shares $103.78 million -3.5%5.5%4.9 $169.44 2/28/2022634,700 shares $118.05 million +0.4%5.7%5.1 $186.00 2/15/2022632,100 shares $120.60 million +14.8%5.7%5.5 $190.80 1/31/2022550,500 shares $109.39 million +17.0%5.0%5 $198.71 1/15/2022470,500 shares $95.96 million -11.8%4.2%4 $203.96 12/31/2021533,300 shares $111.69 million -9.8%4.8%4.5 $209.43 12/15/2021591,100 shares $126.26 million +2.9%5.3%4.8 $213.60 11/30/2021574,600 shares $118.22 million -6.5%5.2%4.6 $205.74 11/15/2021614,300 shares $140.83 million +6.3%5.5%4.7 $229.26 10/29/2021578,100 shares $113.46 million -0.9%5.1%4.4 $196.27 10/15/2021583,500 shares $111.39 million +38.3%5.2%4.7 $190.90 9/30/2021421,800 shares $81.26 million +31.0%3.8%3.6 $192.64 9/15/2021321,900 shares $70.43 million -5.6%2.9%2.9 $218.80 8/31/2021341,000 shares $77.71 million -9.2%3.0%3.2 $227.90 8/13/2021375,400 shares $88.60 million -8.7%3.3%3.7 $236.01 7/30/2021411,000 shares $117.34 million +4.9%3.7%3.6 $285.51Trump Orders 'National Digital Asset Stockpile' (Ad)Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what could be the biggest wealth opportunity since Bitcoin's early days.Click Here to get our complete analysis on why this lending platform is our #1 "buy the dip" opportu 7/15/2021391,800 shares $107.20 million +17.2%3.5%3.4 $273.60 6/30/2021334,200 shares $94.57 million +4.8%3.0%2.9 $282.98 6/15/2021318,900 shares $89.99 million +5.9%2.8%2.7 $282.18 5/28/2021301,100 shares $100.04 million +0.6%2.7%2.4 $332.25 5/14/2021299,200 shares $85.69 million +2.5%2.7%2.4 $286.39 4/30/2021292,000 shares $66.11 million -1.6%2.6%2.4 $226.42 4/15/2021296,800 shares $70.51 million +8.5%2.7%2.5 $237.58 3/31/2021273,500 shares $58.43 million -36.0%2.5%2.2 $213.65 3/15/2021427,400 shares $110.17 million -7.2%3.9%3.3 $257.76 2/26/2021460,700 shares $117.36 million +15.9%4.1%3.7 $254.75 2/12/2021397,600 shares $108.83 million -6.1%3.5%3.1 $273.72 1/29/2021423,600 shares $100.63 million -23.8%3.8%3.1 $237.56 1/15/2021555,900 shares $119.96 million -3.2%5.0%3.8 $215.79 12/31/2020574,500 shares $110.83 million -23.4%5.1%3.9 $192.92 12/15/2020749,700 shares $145.32 million -10.0%6.7%4.9 $193.84 11/30/2020832,600 shares $171.82 million +7.1%7.4%5.2 $206.37 11/15/2020777,700 shares $131.91 million -13.7%6.9%4.4 $169.62 10/30/2020901,600 shares $135.94 million -1.8%8.0%4.6 $150.78 10/15/2020918,500 shares $147.13 million -3.8%8.2%4.4 $160.19 9/30/2020955,100 shares $157.07 million -5.4%8.5%4.1 $164.45 9/15/20201,010,000 shares $178.03 million +5.0%9.0%3.8 $176.27 8/31/2020962,400 shares $156.60 million -25.4%8.6%3.4 $162.72 8/14/20201,290,000 shares $210.17 million -10.4%11.5%4.6 $162.92 7/31/20201,440,000 shares $240.67 million -21.3%12.9%5.1 $167.13 7/15/20201,830,000 shares $281.44 million -39.2%16.3%6.4 $153.79 6/30/20203,010,000 shares $417.70 million -11.7%26.8%10.7 $138.77 6/15/20203,410,000 shares $367.46 million -3.9%30.4%12.8 $107.76 5/29/20203,550,000 shares $363.31 million -0.8%31.6%11.8 $102.34 5/15/20203,580,000 shares $327.10 million +7.8%31.9%10.9 $91.37 MED Short Interest - Frequently Asked Questions What is Medifast's current short interest? Short interest is the volume of Medifast shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 1,200,000 shares of MED short. 11.45% of Medifast's shares are currently sold short. Learn More on Medifast's current short interest. What is a good short interest ratio for Medifast? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. MED shares currently have a short interest ratio of 5.0. Learn More on Medifast's short interest ratio. Which institutional investors are shorting Medifast? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Medifast: K2 Principal Fund L.P., Group One Trading LLC, D. E. Shaw & Co. Inc., Citadel Advisors LLC, Tudor Investment Corp ET AL, Susquehanna International Group LLP, Concourse Financial Group Securities Inc., Walleye Capital LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Medifast? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 11.45% of Medifast's floating shares are currently sold short. Is Medifast's short interest increasing or decreasing? Medifast saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 1,200,000 shares, a drop of 13.0% from the previous total of 1,380,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Medifast's float size? Medifast currently has issued a total of 10,991,000 shares. Some of Medifast's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Medifast currently has a public float of 10,480,000 shares. How does Medifast's short interest compare to its competitors? 11.45% of Medifast's shares are currently sold short. Here is how the short interest of companies compare to Medifast: USANA Health Sciences, Inc. (7.30%), Nu Skin Enterprises, Inc. (4.25%), Nature's Sunshine Products, Inc. (0.45%), Veru Inc. (12.01%), The Estée Lauder Companies Inc. (2.64%), Prestige Consumer Healthcare Inc. (3.39%), Inter Parfums, Inc. (6.52%), Herbalife Ltd. (14.82%), Farmer Bros. Co. (0.97%), Coffee Holding Co., Inc. (3.24%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Medifast stock? Short selling MED is an investing strategy that aims to generate trading profit from Medifast as its price is falling. MED shares are trading up $0.29 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Medifast? A short squeeze for Medifast occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of MED, which in turn drives the price of the stock up even further. How often is Medifast's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MED, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies USNA Short Interest NUS Short Interest NATR Short Interest VERU Short Interest EL Short Interest PBH Short Interest IPAR Short Interest HLF Short Interest FARM Short Interest JVA Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:MED) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medifast, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medifast With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MED Stock Free MED Stock Alerts